Bulletin
Investor Alert

London Markets Close in:

July 29, 2021, 1:46 a.m. EDT

Hepatitis B Virus [HBV] Treatment Market 2021 In-depth Research Studies on Products, Countries, Companies and Industry Segmentation by 2030

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

Jul 29, 2021 (AmericaNewsHour) -- Kenneth Research has recently added a report titled Hepatitis B Virus [HBV] Treatment Market in its storehouse of market research reports. The report provides a detailed insight into the market scenario on the basis of the market size and volume for the forecast period, i.e., 2021 2025. Factors such as the growing advancements in the development of novel drugs, coupled with the growing health infrastructure in several nations worldwide are anticipated to drive the growth of the market in the coming years. Moreover, increasing expenditure on healthcare, backed by the need amongst individuals for quality healthcare services, is also anticipated to contribute to the market growth. According to the statistics by the World Bank, the current health expenditure (% of GDP) around the world increased from 9.08% in 2001 to 9.84% in 2018. Additionally, the current health expenditure per capita (current US$) increased from USD 492.99 in 2001 to USD 1110.84 in 2018. Moreover, growing concern for deaths caused due to various diseases and the need for treatment that can lower the crude death rate, which in the year 2019 recorded close to 7% (per 1000 people), are also anticipated to drive the market growth during the forecast period.

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Hepatitis B Treatment Market by Type (Therapeutics and Vaccines), By End-User (Male and Female) for the regions (North America, Europe, Asia--Pacific and ROW) and By Country (U.S., Canada, U.K., Germany, France, China, India, Japan).

Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic Hepatitis B which results in severe complications, rising awareness about the consequences of viral infection, rigorous efforts to eliminate the viral infection, improving surveillance and diagnostic facilities, significant number of drugs in pipeline with better efficacy coupled with emerging vaccines with lower dosage and better effectiveness. Globally, the growth in Hepatitis B Treatment market is driven by backed by growing middle class population group demanding better drugs to improve lifestyle. 

The Final Report will cover the impact analysis of COVID-19 on this industry:

Get a Sample PDF of Report-
https://www.kennethresearch.com/sample-request-10086014

According to Azoth Analytics research report "Global Hepatitis B Virus [HBV] Treatment Market - Analysis By Type (Therapeutics, Vaccine), By End User (Male, Female) - By Region, By Country: Opportunities and Forecast (2017-2022) - By Region (N. America, Europe, APAC, ROW), By Country (US, Canada, UK, Germany, France, China, India, Japan)", global market is projected to display a growth represented by a CAGR of 5.30% by value during 2017 - 2022, chiefly driven by increase in healthcare spending and improving access to diagnosis for Chronic Hepatitis B, increasing risk of severe complications due to Hepatitis B virus. 

Among the type of treatment, therapeutics accounts for the major market share and anticipated to witness significant growth rate during the forecast period. Among the regions, Asia Pacific is predicted to advance at the highest rate, mainly driven by large population suffering with chronic Hepatitis B virus with unfulfilled need, improving access to healthcare, changing lifestyle and expanding middle class income group.

The report titled, "Global Hepatitis B Virus [HBV] Treatment Market - Analysis By Type (Therapeutics, Vaccine), By End User (Male, Female) - By Region, By Country: Opportunities and Forecast (2017-2022) - By Region (N. America, Europe, APAC, ROW), By Country (US, Canada, UK, Germany, France, China, India, Japan)" has covered and analysed the potential of Hepatitis B Treatment Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global Hepatitis B Treatment market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Market (actual period:2012-2016)(forecast period:2017-2022)? Global Hepatitis B Treatment Market
? Analysis By Type (Therapeutics and Vaccines)
? Analysis By End-User (Male and Female)

Regional Markets - North America, Europe, APAC, ROW (actual period:2012-2016)(forecast period:2017-2022)
? By Type (Therapeutics and Vaccines)
? By End-User (Male and Female)

Country Analysis - United States, Canada, United Kingdom, Germany, France, China, India, Japan (actual period:2012-2016)(forecast period:2017-2022)
? By Type (Therapeutics and Vaccines)
? By End-User (Male and Female)

Other Report Highlights
? Market Dynamics - Trends, Drivers, Challenges, Policy and Regulation
? Company Analysis - Merck and Co; Gilead Sciences; Novartis AG; GlaxoSmithKline, plc; Hoffmann- La Roche; Bristol-Myers Squibb

Customization of the Report
The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research. 

About Kenneth Research:

Kenneth Research provides market research reports to different individuals, industries, associations and organizations with an aim of helping them to take prominent decisions. Our research library comprises of more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both macro level as well as micro level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis on various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keep a track on the international and domestic market for any economic changes impacting the products' demand, growth and opportunities for new and existing players.

Contact Us

Kenneth Research

Email:   Sales@kennethresearch.com

The post Hepatitis B Virus [HBV] Treatment Market 2021 In-depth Research Studies on Products, Countries, Companies and Industry Segmentation by 2030 appeared first on America News Hour .

COMTEX_390591397/2606/2021-07-29T01:45:58

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.